XV International World AIDS Conference, 11-16 July 2004, Bangkok
6 November 2004. Related: Conference reports.
2004
Women and HIV: research directions
6 November 2004. Related: Conference reports, Women's health.
The X4 files: sampling the science on HIV co-receptors in Bangkok
6 November 2004. Related: Conference reports, Antiretrovirals.
10th BHIVA Autumn Conference 8-9 October 2004, London
6 November 2004. Related: Conference reports.
BHIVA audit on management of HIV/Hepatitis coinfection
6 November 2004. Related: Conference reports, Hepatitis coinfection.
A round-up of news about access to treatments with links to sources: Britain, Ukraine, Thailand, Europe, South Africa
6 November 2004. Related: Treatment access.
Body Mass Index at diagnosis is independent predictor of survival
6 November 2004. Related: Treatment access.
Six generics compare well with US-made ARVs
6 November 2004. Related: Antiretrovirals.
Viral load response at 4 weeks predicts treatment success
6 November 2004. Related: Antiretrovirals.
Resistance mutations in patients with persistent viraemia show need to improve clinical assays
6 November 2004. Related: Antiretrovirals.
Researchers call for new approach to assessing pipeline drugs for salvage patients
6 November 2004. Related: Antiretrovirals.
Vancouver researchers urge caution with combinations of lipid drugs
6 November 2004. Related: Side effects, Lipodystrophy and metabolic complications.
3TC resistance leads to hepatitis B flare
6 November 2004. Related: Hepatitis coinfection.
Sight changes reported with PEG-interferon
6 November 2004. Related: Hepatitis coinfection.
BMS submits marketing applications for entecavir to treat HBV in US and Europe
6 November 2004. Related: Hepatitis coinfection.
Study raises questions about cost effectiveness of nevirapine regimen
6 November 2004. Related: Pregnancy.
Low effectiveness of nevirapine to reduce MTCT in real life situation
6 November 2004. Related: Pregnancy.
Use of T-20 at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough
6 November 2004. Related: Pregnancy, Other news.
CHIPS data finds response to HAART varies with age in children
6 November 2004. Related: Paediatric care.
HAART is effective in African children in a resource-limited setting
6 November 2004. Related: Paediatric care.
Predictive factors of virologic success in HIV positive children treated with lopinavir/ritonavir
6 November 2004. Related: Paediatric care.
Clinical features and predictors of survival in patients with AIDS-related non-Hodgkin’s lymphoma
6 November 2004. Related: Coinfections and complications, Cancer and HIV.
Dispersal of HIV-positive asylum seekers: national survey of UK healthcare providers
6 November 2004. Related: Other news.
Medical journals require pre-trial registration in public database as criteria for submission for publication
6 November 2004. Related: Other news.
Conference abstracts and reports
6 November 2004. Related: On the web.
Online medical education
6 November 2004. Related: On the web.
Hepatitis coinfection
6 November 2004. Related: On the web.
Volume 5 Number 9/10 October/November 2004 PDF
1 November 2004. Related: PDFs.
XV International World AIDS Conference, 11-16 July 2004, Bangkok
6 September 2004. Related: Conference reports.
Dollars, commerce, politics and prejudice all present obstacles to scaling up access to treatment in resource poor countries
6 September 2004. Related: Conference reports, Treatment access.
MTCT programmes in South Africa: nevirapine and the minister
6 September 2004. Related: Conference reports, Treatment access, Pregnancy.
Urgency of global access to ARV treatment for IV drug users
6 September 2004. Related: Conference reports, Treatment access, Injecting drug users.
Replace myths with evidence–based policies on IV drug use
6 September 2004. Related: Conference reports, Treatment access, Injecting drug users.
Adding Combivir to single dose nevirapine for reduction of MTCT significantly reduces resistance
6 September 2004. Related: Conference reports, Pregnancy.
Lopinavir/r levels reduced during pregnancy
6 September 2004. Related: Conference reports, Pregnancy.
Another chance for 3TC in patients with M184V mutation?
6 September 2004. Related: Conference reports, Antiretrovirals, Treatment strategies, Drug resistance.
Kaletra monotherapy: small studies and early data
6 September 2004. Related: Conference reports, Antiretrovirals, Treatment strategies.
Lowering dose of d4T can maintain efficacy and reduce side effects
6 September 2004. Related: Conference reports, Antiretrovirals.
Three-year renal safety with tenofovir; cystatin may be a useful marker
6 September 2004. Related: Conference reports, Side effects.
Fluconazole increases nevirapine levels and risk of serious hepatotoxicity
6 September 2004. Related: Conference reports, PK and drug interactions.
Efavirenz interaction with rifampin may not require dose adjustment in patients with low body weight
6 September 2004. Related: Conference reports, PK and drug interactions.
Tipranavir significantly lowers doses of saquinavir, amprenavir and lopinavir/r
6 September 2004. Related: Conference reports, PK and drug interactions.
Responses to hepatitis vaccinations: an optimum window for protection?
6 September 2004. Related: Conference reports, Hepatitis coinfection.
HBV vaccine, CD4 count and increasing response with double-dose
6 September 2004. Related: Conference reports, Coinfections and complications, Hepatitis coinfection.
Response to Hepatitis A (HAV) vaccine determined by CD4 count
6 September 2004. Related: Conference reports, Hepatitis coinfection.
Inventive ways to explain HAART and adherence to children
6 September 2004. Related: Conference reports, Paediatric care.
Isoniazid has early and unexpected benefit in reducing childhood mortality
6 September 2004. Related: Conference reports, Paediatric care.
Lack of keratin overlaying inner foreskin may explain lower HIV infection rates in circumcised men
6 September 2004. Related: Conference reports, HIV prevention and transmission.
A round-up of news about access to treatments with links to sources
6 September 2004. Related: Treatment access.
US FDA approves Glaxo and Gilead drug combinations
6 September 2004. Related: Antiretrovirals.
Abbott applies for once-daily license for lopinavir/r
6 September 2004. Related: Antiretrovirals.
AIDS activists respond to NIH decision on overriding HIV drug patent
6 September 2004. Related: Antiretrovirals.
Efficacy of acetyl-L-carnitine for antiretroviral toxic neuropathy
6 September 2004. Related: Side effects.
Chiron relaxes patent licences for hepatitis C
6 September 2004. Related: Hepatitis coinfection.
Activists arrested in Nepal in homophobic atmosphere
6 September 2004. Related: Other news.
SMART study examines the long term benefit risk of interruptions versus continued use of ART
6 September 2004. Related: Correspondence.
Online treatment journals and newsletters
6 September 2004. Related: On the web.
Volume 5 Number 7/8 August/September 2004 PDF
1 September 2004. Related: PDFs.
Volume 5 Number 6 July 2004
29 July 2004. Related: Editorial.
XIII International HIV Resistance Workshop 8-12 June 2004, Tenerife
29 July 2004. Related: Conference reports.
Risk of NNRTI-resistance during STI: implications for SMART and other STI studies
29 July 2004. Related: Conference reports, Drug resistance.
Persistent nevirapine resistance following mother to child transmission interventions
29 July 2004. Related: Conference reports, Pregnancy, Drug resistance.
Tipranavir resistance and viral response: L90M did not reduce response, recommendation to use with T-20
29 July 2004. Related: Conference reports, Pregnancy, Drug resistance, Other news.
Resistance in the UK: new approach to epidemiological studies
29 July 2004. Related: Conference reports, Drug resistance.